Division of Nephrology and Hypertension

Raymond Harris, MD, left, and Ming-Zhi Zhang, MD, MSc, in the lab. (photo by John Russell)

VUMC discovery one step closer to treatment for kidney fibrosis

Study shows that deletion of EGFR from myeloid cells accelerated recovery from acute kidney injury and reduced subsequent fibrosis.

Elite society honors two VUMC physician-scientists

The Young Physician-Scientist Award recognizes “notable achievements” by researchers who are within five years of their first faculty appointment.

Blockbuster obesity drugs also may slow kidney disease

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.

Three-dimensional imaging of kidney tubules (yellow and green noodle-like structures) under low potassium conditions, which puts the kidney into a state of metabolic overdrive and causes cardiovascular problems.

Low potassium ‘turns on’ kidney proximal tubule: study

A kidney protein that responds to low levels of blood potassium — which can cause high blood pressure and cardiovascular problems — may be a target for new therapeutics.

(iStock image)

VUMC team finds potential treatment for kidney fibrosis

Blood mutations increase risk for acute kidney injury: study

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.

1 2 3 9
OSZAR »